Replies to post #405495 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[couldbebetter]

Thank You Raf! Those numbers look good. Hope we can maintain this and actually
start a trend.

[grbnitz4002]

Thank you Raf , good to see SOME good news

[studythosestocks]

Well that answers the question whether Northstar is marketing yet or not.

Kinda sad that the medical advisor wasn't even for sure "when it would be available" even though it is already on market.

Appreciate the breakdown of generics as well Raf. Very helpful.

[Megc]

Thanks Raf!

[Bolio98]

Wow! Nice.

[rafunrafun]

Scripts for week ending March 10, 2023

Drug Industry TRx: +7.8% w/w; -0.5% y/y

Vascepa
TRx 61,981; +0.9% (+576) w/w; -12.7% y/y
NRx 29,579; +3.3% (+947) w/w; -11.0% y/y
Ref 32,402; -1.1% (-370) w/w; -14.2% y/y

Fake Vascepa
TRx 46,168; +0.2% (+94) w/w; As % of total V: 42.7%
NRx 22,880; -0.1% (-17) w/w; As % of total V: 43.6%
Ref 23,288; +2.8% (+111) w/w; As % of total V: 41.8%

Fake Vascepa by Manufacturer
Hikma TRx 17,291; Gen share 37.5% Total V share 16.0%
Reddy TRx 18,567; Gen share 40.2%; Total V share 17.2%
Apotex TRx 8,724; Gen share 18.9%; Total V share 8.1%
Teva TRx 746; Gen share 1.6%; Total V share 0.7%
Northstar TRx 840; Gen share 1.8%; Total V share 0.8%

Vascepa + Fake Vascepa
TRx 108,149; +0.6% (+670) w/w; +6.4% y/y
NRx 52,459; +1.8% (+929) w/w; +3.3% y/y
Ref 55,691; -0.5% (-259) w/w; +9.6% y/y

Lovaza (Fake & Brand)
TRx 67,125; +1.6% (+1,069) w/w; +5.7% y/y
NRx 33,937; +2.7% (+900) w/w; +2.1% y/y
Ref 33,188; +0.5% (+169) w/w; +9.7% y/y